Stay updated on ITIL-168 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ITIL-168 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the ITIL-168 in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ITIL-168 advanced solid tumors study record is now displayed, with its study overview, eligibility criteria, treatment plan, and outcome measures. The record was previously replaced by a 403 Forbidden error.SummaryDifference47%

- Check15 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision number in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details. This indicates restricted access to the trial record.SummaryDifference18%

Stay in the know with updates to ITIL-168 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ITIL-168 in Advanced Solid Tumors Clinical Trial page.